Evodiamine, as a metabolic-epigenetic regulator, inhibited histone lactylation and HIF 1α expression in prostate Cancer cells, further enhanced Sema 3A transcription, and inhibited PD-L1 transcription, significantly blocking lactate-induced angiogenesis. This evidence concerns the gene CD274 and prostate cancer.